Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-13

FDA Approved: ACETAZOLAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for acetazolamide from ANI Pharmaceuticals, Inc., under ANDA 210588, indicating approval of a change to the approved gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)